StockData
NEXGEL, Inc. logo

NEXGEL, Inc. (NXGL) stock

NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$3.60−0.19 (-5.13%)

Close on Nov 18, 2026Market cap $1.76MP/E –Yield –

Nexgel price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Nexgel's price to sales ratio was 3.4× on Nov 11, 2026, against 25.1× a year earlier. Over the last 5 years it ranged from 2.8× to 141.4×, with a median of 68.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.4×−19.1
2025Dec 31, 202522.5×−67.6
2024Dec 31, 202490.0×+21.1
2023Dec 29, 202369.0×+1.3
2022Dec 30, 202267.7×−71.2
2021Dec 31, 2021138.9×–

More Nexgel figures

See a number that looks wrong?